International Horizon Scanning Initiative To Level Pricing Playing Field
Transparency In Data Is A Key Concern
Nine countries are joining forces on horizon scanning with the aim of improving their chances of securing lower prices for high-cost drugs.
You may also be interested in...
International Horizon Scanning Initiative Moves Forward
An initiative that will improve payers’ ability to negotiate prices for disruptive new drugs is closer to fruition.
Strength in Numbers: EU Cross-Country Drug Pricing Coalitions Join Forces
Two groups of smaller European countries have agreed to collaborate on tackling challenges relating to accessing expensive new medicines.
Strength In Numbers: The Rise Of Cross Country Collaboration In The EU
Countries across the EU have been joining forces over the past few years to discuss and collaborate on pharmaceutical policy issues. They are hoping among other things to secure more sustainable drug prices and get a better grasp on what new medicines are on the horizon.